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ABSTRACT
Introduction: It is widely recognised that many
patients do not take prescribed medicines as advised.
Research in this field has commonly focused on the
role of the patient in non-adherence; however,
healthcare professionals can also have a major
influence on patient behaviour in taking medicines.
This study examines the perceptions, beliefs and
behaviours of healthcare professionalsddoctors,
pharmacists and nursesdabout patient medication
adherence.
Methods and analysis: This paper describes the
study protocol and online questionnaire used in
a cross-sectional survey of healthcare professionals in
Europe. The participating countries include Austria,
Belgium, France, Greece, The Netherlands, Germany,
Poland, Portugal, Switzerland, Hungary, Italy and
England. The study population comprises primary care
and community-based doctors, pharmacists and
nurses involved in the care of adult patients taking
prescribed medicines for chronic and acute illnesses.
Discussion: Knowledge of the nature, extent and
variability of the practices of healthcare professionals
to support medication adherence could inform future
service design, healthcare professional education,
policy and research.
INTRODUCTION
Chronic diseases are a major source of
disability and death worldwide.1 One way of
managing chronic diseases is by taking
medicines. In order for these medicines to
work in the way they are intended, they need
to be taken in the way they were prescribed.
Taking prescribed medicines irregularly or
not at all is often referred to as non-adher-
ence.2 It is widely recognised that many
patients do not take prescribed medication as
advised, and the WHO2 reports that only
around 50% of the general population
in developed countries are adherent to
treatment for chronic diseases. Poor adher-
ence can have a negative impact on both the
potential clinical benefits of treatment3 and
the cost-effectiveness of medicines.4 5 From
the patient’s point of view, non-adherence
can also have positive consequences. For
example, patients who fail to take their
medicines as prescribed avoid the potential
unpleasant side effects of their medicines.
Patients may also benefit from a perception
of autonomy and personal agency through
non-adherence. Healthcare professionals
have a role to play in providing support to
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ARTICLE SUMMARY
Article focus
- A protocol for a cross-sectional survey of
healthcare professionals in Europe to examine
the perceptions, beliefs and behaviours of health-
care professionalsddoctors, pharmacists and
nursesdabout patient medication adherence.
- The questionnaire used in the survey of health-
care professionals is described in detail.
Key messages
- There is an acute need for evidence regarding
healthcare professionals’ beliefs, perceptions and
behaviour with regard to patient non-adherence
to medicines.
- This protocol describes a study to address this
need.
- The results of this study could guide healthcare
professionals as they support patients with
taking medicine in their day-to-day clinical
practice.
Strengths and limitations of this study
- The survey is the largest cross-national survey of
healthcare professionals’ approach to medication
adherence.
- Reliance on self-report data may raise concerns
regarding the validity of the findings.
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patients in order to ensure that if the patient agrees to
take the medicine, it is taken in a way that will maximise
its benefit.
Several studies6 report on the use and effectiveness of
various interventions to improve patient adherence to
medicines. The effectiveness of adherence interventions,
however, needs to be looked at in a broader context
which includes the role of healthcare professionals.
Improving the ability of healthcare professionals to
properly assess the risk of non-adherence and deliver
interventions aimed at reducing non-adherence may lead
to more effective support offered to patients taking
prescribed medicines. In the past, the focus of research
in the field of adherence has been largely on the
patient’s role. In order to gain a fuller understanding of
the problem and address the gap in current knowledge,
this study, which is taking place in several countries across
Europe, looks at the perceptions, beliefs and behaviours
of healthcare professionalsddoctors, nurses and phar-
macistsdwith regards to patient medication adherence.
Knowledge of the nature, extent and variability of the
practices of healthcare professionals to support medica-
tion adherence could inform future service design,
healthcare professional education, policy and research.
This study is part of a larger project on patient medi-
cation adherence funded by the European Commission
called the ‘ABC (Ascertaining Barriers for Compliance)
Project’ (http://www.abcproject.eu). The overall goal of
the ABC project is to produce evidence-based policy
recommendations for improving patient adherence and
by so doing to promote safer, more effective and cost-
effective medicines use in Europe.
METHODS AND ANALYSIS
Design
This paper describes the protocol and questionnaire used
in a cross-sectional survey of healthcare professionals in
Europe. A quantitative self-report questionnaire has been
designed specifically for this study. The questionnaire is
administered online using the survey tool provided by
SurveyMonkey. SurveyMonkey has been successfully used
in published research involving surveys of health care
professionals, and its use has been described in detail by
Dobrow and colleagues.7 For a survey such as this with
widespread geographical coverage, use of the internet
should aid the logistics of survey administration.
Aim
The aim of this study is to ascertain how healthcare
professionalsddoctors, pharmacists and nursesdacross
Europe assess and support patient adherence to
prescribed medication for long-term conditions, with
secondary aims of assessing national and professional
variations in adherence support behaviour.
Objectives
The objectives of this study are to examine healthcare
professionals’ perceptions of the extent of non-adher-
ence, to determine healthcare professionals’ beliefs
about adherence and non-adherence as well as the
behaviours of healthcare professionals to support
patients with taking medicines and their perceptions
about the effectiveness of those actions. The study
will also consider perceived barriers to supporting
adherence as well as training received for managing
non-adherence as reported by healthcare professionals.
Study population
The study is being conducted in several countries across
Europe including Austria, Belgium, France, Greece, The
Netherlands, Germany, Poland, Portugal, Switzerland,
Hungary, Italy and England. The survey is focused on
primary care and community-based doctors, pharmacists
and nurses. These professional groups have been selected
because of their involvement in the care of adults who are
prescribed medicines for chronic and acute conditions.
Inclusion criteria
Healthcare professionals who satisfy the following
criteria are eligible for inclusion in the survey:
a. they are currently employed as medical doctors,
nurses or pharmacists;
b. they work mainly with adults;
c. they work mainly in the community or primary care;
d. they work either in a private or public healthcare
system (or both);
e. they are qualified and registered to practise;
f. they consent to take part in the survey.
Exclusion criteria
Healthcare professionals are not eligible to participate in
the survey if:
a. they are student doctors, nurses or pharmacists;
b. they work only in paediatrics (ie, do not work with
adults at all);
c. they work mainly in secondary care;
d. there is a lack of consent from the healthcare
professional or they decide to quit the study at any
stage and for any reason.
Sample size
The sample size is based on the estimation of the
proportion of those participants who answer ‘never’ to
the primary outcome: ‘I ask patients if they have missed
any doses of their medication’ in each country. Using the
approach in Cochran8 a sample size of 384 healthcare
professionals in each country (128 people in each
professional group) would enable estimation of this
unknown proportion to within an absolute value of 5%
with 95% confidence interval, CI.
Recruitment of participants
A mixed-method approach will be used in order to
recruit participants in each country. A random sample of
healthcare professionals will be sought by sampling from
registers of healthcare professional bodies or associa-
tions. The number of healthcare professionals sampled
and invited to participate in the survey will be based on
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reported9 response rates of healthcare professionals to
online surveys of this nature. Each healthcare profes-
sional that is selected from professional registers will
initially receive a letter inviting them to participate in the
online survey and a project information sheet. The
invitation letter will contain information about the
survey as well as the web link which potential participants
need in order to gain access to the survey. Reminder
letters will then be sent to the healthcare professionals
3 weeks and again 5 weeks after the initial contact.
News articles to promote awareness of the survey will
also be sent to healthcare professional bodies and asso-
ciations for circulation through the respective organisa-
tions’ websites and newsletters. The news article will also
be distributed to publications whose main audience is
healthcare professionals. The news article will contain
information about the study as well as the web link which
healthcare professionals need in order to access the
survey.
All potential participants will be given the same project
information and gain access to the survey via the same
web link.
Data collection commenced at the beginning of July
2011. It is anticipated that data collection in all countries
will cease at the end of March 2012.
Questionnaire development
There are relatively few research studies examining
healthcare professional behaviour with regard to
supporting patients with adherence to medication.
Although it was not possible to identify any validated
scales of healthcare professional behaviour in this
domain, two unvalidated but published questionnaires
which had been used to measure adherence behaviour
among hospital-based doctors10 and cardiovascular
nurses11 were found. The ABC healthcare professional
adherence questionnaire was informed by a combination
of these scales,9 11 as well as recommendations for clinical
practice from published adherence guidelines.2 6 12 13
A subgroup of the ABC research team discussed,
reviewed and edited potential items considered for
inclusion in the questionnaire. The themes covered are:
A. perceptions of the extent of non-adherence to
medication in patients;
B. beliefs about adherence to prescribed medication;
C. use of adherence enhancing interventions;
D. barriers to use of adherence enhancing interven-
tions;
E. questions about training on adherence and use of
guidelines for adherence management
Description of the questionnaire
The questionnaire is made up of 86 items in total and
divided into five subsections. Below is a brief description
of each subsection in the instrument.
A. Perceptions of the extent of patient non-adherence:
This section contains a total of six questions split
equally into two subsections. The first section asks
about healthcare professionals’ perceptions of non-
adherence in all patientsdfor example: ‘what
percentage of all patients with a chronic condition/
illness in your country do you think do not initiate
prescribed medication (ie, patients who do not take
any of their prescribed medication)?’ The second
section asks about their perceptions of non-adher-
ence in their own patientsdfor example: ‘what
percentage of your patients with a chronic condi-
tion/illness in your country do you think do not
initiate prescribed medication (ie., patients who do
not take any of their prescribed medication)?’
A five-point rating scale is provided for respondents
to make their ratings, with response options of
‘0e15%,’ ‘16e35%,’ ‘36e65%,’ ‘66e85%’ and
‘86e100%.’
B. Beliefs about adherence to medicines: There are
seven items in this section. Participants are asked to
indicate the extent to which they agree or disagree
with each statement about patient adherence. For
example, ‘it is possible to improve patient adherence
to medication.’
A five-point rating scale is provided for participants to
make their ratings, with options ranging from
‘strongly disagree’ to ‘strongly agree’ with interme-
diate labels of ‘disagree,’ ‘neither agree nor disagree’
and ‘agree.’ The response category ‘don’t know’ is
also available to respondents.
C. Adherence enhancing interventions used by doctors,
nurses and pharmacists: This section is made up of
a total of 50 questions split into five subsections.
These are:
a. Assessment of adherence and its risk factors:
There are eight items in this subsection. An
example of an item in this section is: ‘I use
electronic monitoring devices to assess patients’
level of adherence.’ The primary outcome is
included in this subsection. The wording for the
question is: ‘I ask patients if they have missed any
doses of their medication.’
b. Providing information for carers and patients:
There are nine items in this subsection. An
example of an item from this section is: ‘I check
that patients understand the information that I
have given them.’
c. Talking with patients about their medications: This
subsection is made up of a total of 18 items. An
example of an item from this section is: ‘I ask
patients what level of involvement they would like
in making decisions about their treatment.’
d. Practical strategies to make medication taking
easier: Eleven items make up this subsection. An
example of an item from this section is: ‘I help
patients to tailor their medication regimen to
their own lifestyle.’
e. Involving others and services to support adher-
ence. This subsection consists of four items in
total. An example of an item from this section is: ‘I
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refer patients to peer mentor programmes to
support medication adherence.’
The response scale for the entire section on adherence
enhancing interventions is adapted from Berben et al’s
survey of adherence practices by European cardiovas-
cular nurses.10 The response options here are split into
two. Respondents are first asked to indicate how often
they use the intervention. A five-point rating scale is
provided for participants to provide their frequency of
use with responses ranging from ‘never’ to ‘all the time’
and intermediate ratings of ‘occasionally,’ ‘sometimes’
and ‘frequently.’ The response category ‘not applicable’
is made available to participants who do not use any of
the interventions mentioned. Next, respondents are
given the opportunity to indicate, for every intervention
they use, how effective they think that intervention is. A
three-point rating scale is provided; with responses
ranging from ‘not at all’ to ‘extremely,’ with an inter-
mediate category ‘somewhat.’ The response category
‘not applicable’ is provided for those who select the
option ‘not applicable’ in column 1.
D. Barriers to the use of adherence management
practices by healthcare professionals: This section
contains 13 questions. An example of an item from
the list is: ‘I have an excessive workload that prevents
me from supporting patients with medicine adher-
ence.’ A four-point rating scale is provided for
participants to indicate the extent to which the
items listed act as barriers to their use of adherence
promoting interventions. The options range
from ‘not at all’ to ‘very much’ with intermediate
options of ‘slightly’ and ‘moderately.’ The response
option ‘not applicable’ is provided for those who do
not consider an item to be relevant to their work
setting.
E. A final set of three questions about previous training
in medication adherence and use of adherence
guidelines completes the questionnaire. The ques-
tions ask whether the healthcare professional has had
any training in adherence management during
preregistration or postregistration training. Respon-
dents are also asked if they make use of any
practitioner guidelines to manage patient adherence.
The response options are ‘yes’ or ‘no.’
Outcomes
Primary outcome
The primary outcome is the frequency of assessing the
likelihood of non-adherence: This will be based on the
response to the question ‘I ask patients if they have
missed any doses of their medication.’
Secondary outcomes
The following secondary outcomes will be reported:
< Perception of the extent of non-adherence: This
measure is based on the participants’ responses to
a series of six questions that ask about their
perceptions of the levels of non adherence in all
patients versus their patients.
< Beliefs about adherence: This is based on an
assessment of healthcare professionals’ beliefs about
patient adherence.
< Methods used to support patients with medication
taking: This is a measure of healthcare professionals’
behaviour. Fifty items provide a measure of what
healthcare professionals do to support patients with
medicine taking.
< Barriers to the use of adherence enhancing practices:
Participants are asked to indicate the extent to which
the 13 items listed act as barriers that limit their use of
interventions to improve adherence.
< In addition, demographic information about the
respondents will be collected, including healthcare
setting (eg, community setting, private or state-
funded healthcare system), number of years since
registration as a healthcare professional, gender, age
and average length of consultations with patients
about medicines.
Analysis
Analyses will be conducted by total sample, country and
professional group. No interim analysis is planned.
Analysis of primary outcome
For all countries, the number and proportion of partic-
ipants with the primary outcome will be reported overall
and in each country, as will 95% CIs for the proportions.
Comparisons between countries and professions will be
performed using multilevel random models using
the software MLwiN (http://www.cmm.bristol.ac.uk/
MLwiN/) for both binary and ordered categories. The
software has the advantage of dealing with missing values
by using all available data on each individual and not by
imputing missing values.
Point estimates of the proportion of healthcare
professionals who assess adherence in the entire sample
(primary outcome) as well as in each country and each
profession and their associated 95% CIs will be obtained.
Analysis of secondary outcomes
For the entire sample and each group, the medians,
modes, IQRs and frequency distributions will be
reported for each secondary outcome, and 95% CIs for
the medians will be reported. Comparisons between and
within countries and professions will be performed using
multilevel models using all ordered categories and which
will also include demographic and other information on
participants (see below). The following comparisons of
outcomes will be performed:
< comparisons between the participating countries;
< comparisons between each professional group;
< comparisons by country and profession.
Description of samples
Characteristics of participants will be described for the
sample as a whole, for each country and for each
profession. Participants will be described in terms of
their healthcare setting, type of healthcare system,
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number of years since licensed to practise, average
length of time consulting with patients about medicines,
age, gender and country.
Data-handling
Only the research team at Keele University will have
access to the data during the study. After the study is
completed, Keele University will make available the
relevant data to ABC project partners for analysis, as
appropriate.
Ethics and dissemination
Consent
Respondents who accept the invitation to take part in
the study, and use the link provided to access the survey
web page, are taken to the survey introductory page.
Here, the participants are provided with information
about the project, anonymity of the survey findings, an
outline of what participants are required to do and how
long it will take to complete the questions, an assurance
that every attempt will be made to ensure the confi-
dentiality of the data and a statement indicating that
participation is voluntary and that withdrawal from the
survey is possible at any stage. Potential participants are
asked to click on a link to confirm that they have read
the participant information before proceeding. The act
of clicking on this link is considered consent to partici-
pate in the study. Access to the survey is denied unless
this link is clicked.
Confidentiality
No personal information (such as names, addresses and
professional licence numbers) will be collected from
participants. The survey is completely anonymous, and
no IP addresses will be stored or downloaded.
Quality assurance
During the preparation of the study, quality has been
ensured through the process of translation and back-
translation of research questionnaires. The question-
naire and the associated survey materials have been
translated into the official language(s) for each partici-
pating country. The work-flow and quality-management
processes employed are certified to meet ISO 9001
Quality Management Standards. Forward translations
have been performed by highly trained, approved and
accredited translators who are native speakers of the
target languages and fluent in English. Back-translations
have been performed by persons who are native English
speakers and fluent in each target language. A third
individual acts as a reviewer, highlights any discrepancies
between the forward and back translations, and resolves
them by discussion with the translators. The respective
national coordinators and their teams for each partici-
pating country also proofread each translated document
and provide feedback on grammatical errors. They also
provide contextual interpretation of the translations to
ensure that they reflect the appropriate terminology
used in each participating country. In addition to this,
the online survey is piloted by at least five people in each
country in order to check its technical functionality and
also to check for comprehensibility and formatting
errors.
The ABC research team at Keele University will have
overall responsibility for the design, recruitment,
management, analysis of data and interpretation of
results as well as writing the report. The ABC Project
partners (First Department of Family Medicine, Medical
University of Lodz, Poland, Center for Health Services
and Nursing Research, Katholieke Universiteit,
Belgium, Aardex Group, Switzerland, Bangor University,
Wales) participated in the design of the study. ABC
partners will manage recruitment and data collection in
their respective countries and also contribute to the
interpretation of the results and their dissemination.
The ABC project partners share all decisions about
research developments and outputs, determining
decisions by vote if appropriate. The funder of the
research, the FP7 programme of the European
Commission, is not involved in the design or interpre-
tation of the study.
Dissemination
The results will also be published in internal reports, in
peer-reviewed scientific journals as well as via conference
presentations. The results of the study will also be avail-
able to the public on the ABC project website (http://
www.ABCproject.eu) and via press releases in each of the
participating countries.
DISCUSSION
To our knowledge, this study is the largest survey of
European healthcare professionals’ medication adher-
ence perceptions, beliefs and behaviours. It is expected
that the results will inform our understanding of how
healthcare professionals perceive medication non-
adherence. This study will also provide some insight into
how healthcare professionals respond to non-adherence
to prescribed medication in their patients. By gaining
a deeper understanding of healthcare professionals’
perceptions and behaviour with regards to non-adher-
ence in their patients, researchers will be able to design
educational interventions and training for healthcare
professionals that are evidence-based and targeted at the
training needs of healthcare professionals.
This study will also provide information on the inter-
ventions most frequently used by healthcare profes-
sionals and their perceptions of which interventions are
most effective in managing non-adherence. It is antici-
pated that this will provide evidence-based knowledge of
interventions which healthcare professionals have found
to be effective at improving patient adherence. Health-
care professionals could use this information as a guide
when making a decision about which interventions to
make use of or to recommend to patients in order to
improve adherence. Information on those interventions
which are reported to be less effective could help to
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channel the efforts of researchers towards finding ways
to improve those interventions.
The Pan-European nature of this study will provide
a comprehensive data set which will enable analysis of
variability observed in healthcare professionals’ beliefs
and behaviours across 12 European nations. It is antici-
pated that this knowledge of the level of variability
between professions in adherence-supporting behaviour
may provide a basis for promoting routine and contin-
uous efforts to educate and modify the behaviour of
healthcare professionals in order to enable them to fulfil
their roles in supporting patients with medicine taking.
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